Journey Medical (NASDAQ:DERM) reported its Q4 earnings results on Thursday, March 21, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Journey Medical beat estimated earnings by 138.0%, reporting an EPS of $0.03 versus an estimate of $-0.08.
Revenue was down $709 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.14 which was followed by a 10.0% increase in the share price the next day.
Here's a look at Journey Medical's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.33 | -0.45 | -0.47 |
| EPS Actual | 0.99 | -0.04 | -0.30 | -0.17 |
| Revenue Estimate | 16.88M | 14.81M | 16.18M | 16.58M |
| Revenue Actual | 34.54M | 17.17M | 12.21M | 15.97M |
To track all earnings releases for Journey Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.